Illumination devices for inducing biological effects
Illumination devices for impinging light on tissue, for example within a body cavity of a patient, to induce various biological effects are disclosed. Biological effects may include at least one of inactivating and/or inhibiting growth of one or more pathogens, upregulating a local immune response, increasing endogenous stores of nitric oxide, releasing nitric oxide from endogenous stores, and inducing an anti-inflammatory effect. Wavelengths of light are selected based on intended biological effects for one or more of targeted tissue types and targeted pathogens. Light treatments may provide multiple pathogenic biological effects, either with light of a single wavelength or with light having multiple wavelengths. Devices for light treatments are disclosed that provide light doses for inducing biological effects on various targeted pathogens and tissues with increased efficacy and reduced cytotoxicity. Illumination devices may be configured to communicate with networks and/or servers to provide control and/or management of phototherapy treatments.
1. An illumination device comprising:
at least one light source;
at least one camera;
a communication module; and
driver circuitry associated with the communication module, the at least one light source, and the at least one camera, the driver circuitry configured to:
control the at least one camera to capture one or more images of a target area of the mammalian tissue and relay the one or more images to a server via the communication module;
receive a treatment protocol comprising at least one parameter from the server via the communication module, the treatment protocol comprising one of a pre-exposure prophylaxis treatment, a post-exposure prophylaxis treatment based on identification of at least one pathogen in a cell-free environment with respect to a surface of the mammalian tissue, and a post-infection treatment based on identification of at least one pathogen in a cell-associated environment with respect to the mammalian tissue; and
control the at least one light source to irradiate the light on the target area of the mammalian tissue to induce at least one biological effect.
2. The illumination device of claim 1 , wherein the at least one parameter comprises one or more of a duration, an intensity, a peak wavelength, or a range of peak wavelengths of the light.
3. The illumination device of claim 1 , wherein the mammalian tissue comprises one or more tissues of an oral cavity, an oropharyngeal area, a throat, a larynx, a pharynx, an oropharynx, a trachea, an esophagus, and a lung.
4. The illumination device of claim 1 , further comprising a sensor for collecting data from the mammalian tissue.
5. The illumination device of claim 4 , wherein the communication module is configured to communicate the data from the mammalian tissue to the server.
6. The illumination device of claim 4 , wherein the data from the mammalian tissue comprises one or more of temperature data, proximity data, blood pressure data, heart rate data, pulse oximeter data, the presence or concentration of a chemical species, the presence or concentration of a biological species, and moisture data.
7. The illumination device of claim 1 , wherein a location of the target area of the mammalian tissue is identified based on camera pixelated measurements of the one or more images.
8. The illumination device of claim 7 , wherein the location of the target area of the mammalian tissue is further identified based on global positioning system data of the one or more images.
9. A method comprising:
accessing data related to mammalian tissue, the data comprising one or more of image data and sensor data of the mammalian tissue obtained by an illumination device, the data further comprising information collected from diagnostic testing obtained separately from the illumination device;
generating a treatment protocol comprising one of a pre-exposure prophylaxis treatment, a post-exposure prophylaxis treatment based on identification of at least one pathogen in a cell-free environment with respect to a surface of the mammalian tissue, and a post-infection treatment based on identification of at least one pathogen in a cell-associated environment with respect to the mammalian tissue, the treatment protocol including identifying at least one parameter and at least one medication for treatment based on the data related to the mammalian tissue by inferring a characteristic of the mammalian tissue based on a comparison of the data related to the mammalian tissue with other data that corresponds with previously identified mammalian tissue characteristics; and
sending the at least one parameter to the illumination device comprising at least one light source being capable of irradiating the light on the mammalian tissue based on the at least one parameter to induce at least one biological effect in combination with administering the at least one medication.
10. The method of claim 9 , wherein the at least one parameter comprises one or more of a duration, an intensity, a peak wavelength, or a range of peak wavelengths of the light.
11. The method of claim 9 , wherein the mammalian tissue comprises one or more tissues of an auditory canal, a nasal cavity, an oral cavity, an oropharyngeal area, a throat, a larynx, a pharynx, an oropharynx, a trachea, an esophagus, a lung, endothelial tissue, and gastrointestinal tissue.
12. A system comprising:
an illumination device comprising at least one light source arranged to irradiate light on mammalian tissue; and
a server in communication with the illumination device via a network, wherein the server is configured to provide a treatment protocol comprising one of a pre-exposure prophylaxis treatment, a post-exposure prophylaxis treatment based on identification of at least one pathogen in a cell-free environment with respect to a surface of the mammalian tissue, and a post-infection treatment based on identification of at least one pathogen in a cell-associated environment with respect to the mammalian tissue, the treatment protocol including at least one changeable attribute for the illumination device to irradiate the light on the mammalian tissue to induce at least one biological effect, the at least one changeable attribute comprising identification of one or more of an optic, a locator, a light source positioner, and a light guide positioner for removable attachment to the illumination device relative to the at least one light source.
13. The system of claim 12 , wherein the treatment protocol further comprises at least one parameter, and the at least one parameter comprises one or more of a duration, an intensity, a peak wavelength, or a range of peak wavelengths of the light.
14. The system of claim 12 , wherein the mammalian tissue comprises one or more tissues of an auditory canal, a nasal cavity, an oral cavity, an oropharyngeal area, a throat, a larynx, a pharynx, an oropharynx, a trachea, an esophagus, a lung, endothelial tissue, and gastrointestinal tissue.
15. The system of claim 12 , wherein the network comprises at least one of an intranet, an internet, a wide area network (WAN), a local area network (LAN), a personal area network (PAN), power line communications (PLC), and a cellular network.
16. The system of claim 12 , wherein the server comprises an artificial intelligence library that is populated with data that corresponds with previously identified mammalian tissue characteristics.
17. The system of claim 16 , wherein the server comprises a server-side application that is configured to collect usage data from other illumination devices and add the usage data to the artificial intelligence library.
18. The system of claim 17 , wherein the server-side application is configured to:
infer a characteristic of the mammalian tissue based on a comparison of data collected from the mammalian tissue with the data of the artificial intelligence library that corresponds with previously identified mammalian tissue characteristics; and
provide the treatment protocol to the illumination device.
19. The system of claim 18 , wherein the data collected from the mammalian tissue comprises one or more images of the mammalian tissue.
20. The system of claim 19 , wherein the one or more images comprise at least one of visible-light images, infrared images, ultraviolet images, images measuring light within a predetermined range of wavelengths, and images measuring light within two or more different predetermined ranges of wavelengths.
21. The system of claim 18 , wherein the data collected from the mammalian tissue comprises sensor data of the mammalian tissue.
22. The system of claim 18 , wherein the illumination device comprises at least one of a camera and a sensor, and the data collected from the mammalian tissue is captured by the at least one of the camera and the sensor of the illumination device.
23. The system of claim 22 , wherein the data collected from the mammalian tissue further comprises other tissue diagnostics that are provided separately from the illumination device.
24. The system of claim 18 , wherein the previously identified mammalian tissue characteristics comprise a presence of at least one of pathogens, diseases, cancerous lesions, pre-cancerous lesions, tumors, polyps, accumulation of fluid, and inflammation.
25. The system of claim 12 , further comprising a computing device in communication with the server and the illumination device, the computing device comprising one or more of a laptop computer, a tablet, a desktop computer, another server, a cellular phone, a personal digital assistant (PDA), a multimedia player, an embedded system, a wearable device, a smart watch, smart glasses, and a gaming console.
26. The system of claim 12 , wherein the at least one biological effect comprises at least one of inactivating the at least one pathogen that is in the cell-free environment, inhibiting replication of the at least one pathogen that is in the cell-associated environment, upregulating a local immune response, stimulating enzymatic generation of nitric oxide to increase endogenous stores of nitric oxide, releasing nitric oxide from endogenous stores of nitric oxide, and inducing an anti-inflammatory effect.
27. The system of claim 12 , wherein the illumination device comprises a rechargeable power source that is configured to receive power from an external power source.
28. The system of claim 27 , wherein the external power source is configured to provide the power in response to human movements.
29. The system of claim 27 , wherein the external power source comprises a solar energy source.